🔴 Picard Medical is trading 6.6% down after rebound, with no clear catalyst identified

Picard Medical is trading 6.6% down at $7.97, with no clear company-specific catalyst identified.

• The decline follows a sharp multi-session rebound, including a 26.12% gain on October 6.
• Available coverage described the earlier pre-market weakness as having no clear catalyst.
• Broader markets are weaker as investors await the Federal Reserve minutes, but available information does not establish this as the reason for the stock’s move.